Nationwide Fund Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

Nationwide Fund Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,000	Closed	-$23K	–	2818
2017 Q3	$23K	Hold	2,000	–	–	﹤0.01%	3102
2017 Q2	$84K	Buy	+2,000	New	+$96.3K	﹤0.01%	2969
2016 Q2	–	Sell	-1,729	Closed	-$107K	–	3338
2016 Q1	$107K	Hold	1,729	–	–	﹤0.01%	2791
2015 Q4	$73K	Buy	1,729 +187	+12%	+$8.91K	﹤0.01%	2927
2015 Q3	$85K	Buy	1,542 +60	+4%	+$5.95K	﹤0.01%	2942
2015 Q2	$163K	Buy	1,482 +1,096	+284%	+$102K	﹤0.01%	2813
2015 Q1	$37K	Hold	386	–	–	﹤0.01%	3134
2014 Q4	$22K	Hold	386	–	–	﹤0.01%	3090
2014 Q3	$28K	Hold	386	–	–	﹤0.01%	3145
2014 Q2	$58K	Buy	386 +236	+157%	+$35.8K	﹤0.01%	3089
2014 Q1	$22K	Buy	+150	New	+$18.4K	﹤0.01%	2907

Other funds holding GNCA

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Nationwide Fund Advisors's GNCA Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2017, closing a stake of 2,000 shares — an estimated $23K sold.

Nationwide Fund Advisors first reported a position in GNCA in Q1 2014 and held it in 11 quarters. The position peaked at $163K in Q2 2015. 56 funds tracked by Wall St. Rank hold GNCA as of Q4 2017.

Nationwide Fund Advisors reported no remaining Genocea Biosciences, Inc. position as of Q4 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 2,000 Genocea Biosciences, Inc. shares in Q4 2017, an estimated $23K.
Nationwide Fund Advisors first reported a position in Genocea Biosciences, Inc. in Q1 2014 and held it in 11 quarters.
Nationwide Fund Advisors's Genocea Biosciences, Inc. position peaked at $163K in Q2 2015.
56 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.